The upregulation of FoxO1 in the liver has been associated with NASH, obesity, and insulin resistance, meanwhile hepatic FoxO1/3 knockout mice exhibit lower blood glucose levels and increased glucose tolerance (Rametta et al., 2013; Xiong et al., 2013). Here, FOXO1 is linked to metabolic dysfunction-associated steatohepatitis.